share_log

HC Wainwright & Co. Maintains Buy on Gossamer Bio, Raises Price Target to $10

Benzinga ·  Jan 8 06:27

HC Wainwright & Co. analyst Patrick Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and raises the price target from $5 to $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment